Teachers Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Teachers Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$99M	Buy	732,199 +421,595	+136%	+$52.4M	0.12%	170
2018 Q4	$30.2M	Sell	310,604 -119,804	-28%	-$14.2M	0.04%	439
2018 Q3	$59.8M	Sell	430,408 -2,766	-0.6%	-$347K	0.07%	302
2018 Q2	$53.8M	Sell	433,174 -420,726	-49%	-$49.2M	0.07%	335
2018 Q1	$95.2M	Buy	853,900 +109,793	+15%	+$13.1M	0.12%	184
2017 Q4	$89M	Buy	744,107 +126,250	+20%	+$15.4M	0.11%	197
2017 Q3	$86.7M	Sell	617,857 -378,073	-38%	-$51.4M	0.12%	200
2017 Q2	$121M	Buy	995,930 +573,663	+136%	+$66.8M	0.17%	131
2017 Q1	$51.2M	Buy	422,267 +12,179	+3%	+$1.57M	0.07%	329
2016 Q4	$50.2M	Sell	410,088 -186,795	-31%	-$22.9M	0.08%	301
2016 Q3	$73.1M	Sell	596,883 -156,950	-21%	-$20.2M	0.12%	197
2016 Q2	$88M	Buy	753,833 +214,483	+40%	+$30.4M	0.15%	157
2016 Q1	$75.1M	Buy	539,350 +47,070	+10%	+$6.91M	0.14%	169
2015 Q4	$93.9M	Buy	492,280 +38,395	+8%	+$6.71M	0.18%	116
2015 Q3	$71M	Sell	453,885 -272,862	-38%	-$49.8M	0.14%	162
2015 Q2	$131M	Buy	726,747 +205,429	+39%	+$35.5M	0.24%	68
2015 Q1	$90.3M	Buy	521,318 +76,426	+17%	+$13.8M	0.17%	138
2014 Q4	$82.3M	Buy	444,892 +34,378	+8%	+$6.37M	0.16%	148
2014 Q3	$68.1M	Sell	410,514 -44,191	-10%	-$7.26M	0.14%	177
2014 Q2	$71M	Sell	454,705 -55,723	-11%	-$8.8M	0.15%	160
2014 Q1	$77.7M	Sell	510,428 -268,316	-34%	-$42.7M	0.17%	134
2013 Q4	$104M	Sell	778,744 -47,652	-6%	-$5.72M	0.23%	80
2013 Q3	$96M	Buy	826,396 +183,717	+29%	+$20.2M	0.24%	77
2013 Q2	$59.3M	Buy	+642,679	New	+$61.9M	0.16%	141

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Teachers Advisors's ALXN Position: Q1 2019 in Review

Teachers Advisors increased its Alexion Pharmaceuticals (ALXN) stake by 136% in Q1 2019, buying an estimated $52.4M and bringing the position to 732,199 shares worth $99M. The position accounts for 0.12% of the portfolio, ranked #170.

Teachers Advisors first reported a position in ALXN in Q2 2013 and has held it in 24 quarters since. The position peaked at $131M in Q2 2015. 612 funds tracked by Wall St. Rank hold ALXN as of Q1 2019.

Teachers Advisors held 732,199 shares of Alexion Pharmaceuticals worth $99M as of Q1 2019.
Teachers Advisors bought 421,595 Alexion Pharmaceuticals shares in Q1 2019, an estimated $52.4M.
Alexion Pharmaceuticals made up 0.12% of Teachers Advisors's portfolio in Q1 2019, its #170 holding.
Teachers Advisors first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
Teachers Advisors's Alexion Pharmaceuticals position peaked at $131M in Q2 2015.
612 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.